COVID-19 situation: 6 July 2020
To view images in this newsletter, please allow images and html options.
Pandemic Threats and Health Emergencies
COVID-19 situation: 6 July 2020
Welcome to this special issue of the newsletter where we highlight latest research and policy news and literature on COVID-19 situation
Please send your feedback, articles and reports, or questions you would like to share to Dr. Chadia Wannous via email email@example.com
Wishing you useful reading!
WHO situation report 167 by 5 July 2020
More info: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200705-covid-19-sitrep-167.pdf
Links to the COVID-19 dashboards for most up-to-date figures:
Global dashboard https://covid19.who.int/
WHO COVID-19 alerts in African Region
WHO COVID-19 readiness dashboard in African Region
WHO COVID-19 situation dashboard in European Region
WHO COVID-19 weekly surveillance dashboard in European Region
WHO COVID-19 situation dashboard in the Eastern Mediterranean Region
PAHO COVID-19 alerts in the Region of the Americas
All information about COVID- 19 can be found here:https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Latest updates - Live press conference (Geneva)
Situation updates in the Region of the Americas
July 5th, 2020 15:00 (EST)
An additional 122,886 cases and 2,488 deaths were reported in the past 24 hours, representing a 2% relative increase in cases and a 1% relative increase in deaths, compared to the previous day.
The United States of America accounts for 49% of all cases and 49% of all deaths for the Region of the Americas and Brazil accounts for 27% of all cases and 24% of all deaths. Combined, these two countries account for 76% of all cases and 73% of all deaths currently reported in the Region.
Situation update for the EU/EEA and the UK as of 5 July 2020
As of 05 July 2020, 1 549 904 cases have been reported in the EU/EEA and the UK: United Kingdom (284 900), Spain (250 545), Italy (241 419), Germany (196 335), France (166 960), Sweden (71 419), Belgium (61 909), Netherlands (50 493), Portugal (43 569), Poland (35 719), Romania (28 582), Ireland (25 509), Austria (18 196), Denmark (12 832), Czechia (12 440), Norway (8 895), Finland (7 248), Bulgaria (5 677), Luxembourg (4 476), Hungary (4 183), Greece (3 511), Croatia (3 094), Estonia (1 993), Iceland (1 860), Lithuania (1 831), Slovakia (1 749), Slovenia (1 679), Latvia (1 123), Cyprus (1 002), Malta (672) and Liechtenstein (84).
As of 05 July 2020, 178 082 deaths have been reported in the EU/EEA and the UK: United Kingdom (44 198), Italy (34 854), France (29 893), Spain (28 385), Belgium (9 771), Germany (9 012), Netherlands (6 117), Sweden (5 420), Ireland (1 741), Romania (1 731), Portugal (1 605), Poland (1 512), Austria (705), Denmark (606), Hungary (589), Czechia (351), Finland (329), Norway (251), Bulgaria (241), Greece (192), Croatia (113), Slovenia (111), Luxembourg (110), Lithuania (79), Estonia (69), Latvia (30), Slovakia (28), Cyprus (19), Iceland (10), Malta (9) and Liechtenstein (1).
Situation dashboard: latest available data
US posts largest single-day jump in new COVID-19 cases
With the nation entering the 4th of July holiday, Florida had a record high of more than 10,000 cases, and surging cases in Texas triggered an executive order to wear masks.
Financial crisis at PAHO in the time of COVID-19: a call for action
On May 21, 2020, at a special session of the Executive Committee of the Pan American Health Organization (PAHO), WHO Regional Office for the Americas, Carissa Etienne, Regional Director, declared that due to non-payment of Member States' contributions, PAHO stands on the brink of insolvency. As of April 30, 2020, most of the non-payment is attributable to the USA (67%); however, late payments are outstanding from Brazil, Venezuela, Mexico, Argentina, Colombia, Chile, and others, to a total of US$164·6 million. This includes an unprecedented $63·8 million (57%) of 2019 assessed contributions.
This financial crisis could not have occurred at a worse time. The Americas have recorded the greatest COVID-19 morbidity and mortality of any region. As of June 25, 2020, the COVID-19 Information System for the Region of the Americas has recorded 4·6 million cases and 230 400 deaths in 54 countries. The trajectory is worsening.
Coronavirus: why a blanket ban on wildlife trade would not be the right response
Blanket bans are unlikely to benefit people or wildlife, and are unfeasible because they overlook the complexity of the wildlife trade. The COVID-19 outbreak should not be used opportunistically to prescribe global wildlife trade policy. A more appropriate response would be to improve wildlife trade regulation with a direct focus on human health.
Reflecting on experiences of social distancing
An international collaboration, to study the phenomenological effects of social distancing, and of the pandemic more generally. We seek to obtain a substantial and diverse collection of personal accounts via surveys and interviews. As well as furthering our research, these testimonies will be turned into a publicly available resource. The online survey is open to participants worldwide.
Post COVID-19: a solution scan of options for preventing future zoonotic epidemics
Last week, an international team of wildlife and veterinary experts released an extensive list of ways to change our relationship with animals and reduce the risk of another pandemic like COVID-19. Laws to prevent different animal species mixing, improving animal health on farms by limiting stocking densities, ensuring high standards of veterinary care, and shifting to plant-based foods are among the many feasible options to consider further.
Reopening US Schools in the Era of COVID-19: Practical Guidance From Other Nations
Scientific Publications, Reports and News
World's scientists gather for research update on COVID-19
Over 1000 global researchers and scientists gathered for a virtual summit to review the latest data from the WHO Solidarity Trial and other trials for potential treatment and vaccines. Here's what they found.
Six months of coronavirus: the mysteries scientists are still racing to solve
From immunity to the role of genetics, Nature looks at five pressing questions about COVID-19 that researchers are tackling.
To unequivocally trace the virus’s journey to people, scientists would need to find an animal that hosts a version more than 99% similar to SARS-CoV-2 — a prospect complicated by the fact that the virus has spread so widely among people, who have also passed it to other animals, such as cats, dogs and farmed mink.
HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa.
A guide to R — the pandemic’s misunderstood metric
What the reproduction number can and can’t tell us about managing COVID-19.
About 30% of COVID deaths may not be classified as such
In the first 3 months of the pandemic, excess US deaths were 28% higher than reported COVID-19 deaths.
Antibiotic use, duration questioned for kids' pneumonia in low-resource areas
One study finds that a 3-day antibiotic course is non-inferior to a 5-day course.
Prevalence of and Risk Factors Associated with Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic
The COVID-19 Pandemic Underscores the Need to Address Structural Challenges of the US Health Care System
Indigenous leaders angry about coronavirus risk from Brazilian military visit
Leaders of an isolated indigenous community in Brazil complain that a military mission to protect them is actually causing a greater risk of infection
Responding to a measles outbreak during the COVID-19 pandemic
Going village to village, “door to door” and “boat to boat” to maintain routine immunization services — and protect Cambodians from COVID-19
COVID-19 in the Caribbean small island developing states: lessons learnt from extreme weather events
What do we know about the relationship between air pollution and COVID-19? A lot, although it is not conclusive yet.
The global COVID-19 lockdown to contain the spread of the virus has severely restricted economic activity, and reports are emerging from across the globe of blue skies becoming visible, in some cases for the first time in people’s lifetime. These improvements will likely dissipate as lockdowns are lifted, and economic activity resumes. Will the air once again become polluted, or is there a possibility for countries to use economic recovery programs to grow back stronger and cleaner?
Fever checks are a flawed way to flag Covid-19 cases. Experts say smell tests might help
Temperature checks are a flawed way to catch Covid-19 cases. But a growing body of science suggests adding smell tests to screenings might help.
Sewage-based surveillance suggestion
Testing wastewater samples for the coronavirus could help local authorities to identify and tackle COVID-19 outbreaks sooner, scientists say. Studies in the United Kingdom suggest that this approach could help to detect infection spikes up to ten days earlier than existing medical-based tests. “By sampling wastewater at different parts of the sewerage network, we can gradually narrow an outbreak down to smaller geographical areas, enabling public-health officials to quickly target interventions,” says pollution scientist Andrew Singer. “It seems obvious that we should be doing this.”
BBC News | 5 min read
Read more: How sewage could reveal the true scale of the coronavirus outbreak (Nature | 4 min read, from April)
Active case finding with case management: the key to tackling the COVID-19 pandemic
United States buys nearly all the remdesivir
The US Health Department has announced that it is buying almost all of the next three months’ production of the antiviral drug remdesivir from US company Gilead. Clinical trials suggest that the drug can speed up recovery from coronavirus infection in people with severe COVID-19, although it is still unknown whether the treatment can increase survival rates. Critics say the move undermines international efforts to fight the pandemic. "It so clearly signals an unwillingness to co-operate with other countries and the chilling effect this has on international agreements about intellectual-property rights,” says science-policy researcher Ohid Yaqub.
BBC News | 4 min read
The trial transforming COVID-19 treatment
The United Kingdom’s large-scale trial Recovery (Randomised Evaluation of COVID-19 Therapy) stands out among the dozens of ongoing clinical studies that aim to test potential treatments for coronavirus infection. Involving more than 12,000 participants from hundreds of hospitals, the effort has delivered widely accepted verdicts on the potential of several antiviral drugs, and provided insights that have changed how physicians around the world consider treating COVID-19. Meanwhile, other large-scale initiatives have struggled to recruit participants and been slow to deliver results.
Science | 8 min read
Does asthma increase Covid-19 risk? Emerging research suggests a complicated connection
A growing body of research suggests that people with different types of asthma face different levels of risk when it comes to Covid-19.
Pulse oximetry in low-resource settings during the COVID-19 pandemic
Oxygen availability in sub-Saharan African countries: a call for data to inform service delivery
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Nobel winners call for coronavirus vaccines to be available for all
Horseshoe crab blood is key to making a COVID-19 vaccine—but the ecosystem may suffer.
Conservationists worry that horseshoe crabs, a food source for many species, will decline amid the rush for a vaccine. Drug companies say there's more than enough supply.
Here’s how we’ll know when a COVID-19 vaccine is ready
Health officials have set targets for how good and how safe a COVID-19 vaccine needs to be, but communicating that to the public can present challenges.
Trial of Moderna Covid-19 vaccine delayed, investigators say, but July start still possible
Investigators say the delay was prompted by changes to the trial plan, called a protocol, while stressing such changes are common.
Consequences of the Outbreak on society and Economy
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study
In the COVID-19 pandemic in Brazil, do brown lives matter?
EU guidance impedes humanitarian action to prevent COVID-19 in Syria
Moral Distress among Disaster Responders: What is it?
Health inequity during the COVID-19 pandemic: a cry for ethical global leadership
Attitudes and Psychological Factors Associated With News Monitoring, Social Distancing, Disinfecting, and Hoarding Behaviors Among US Adolescents During the Coronavirus Disease 2019 Pandemic
The new normal: Covid-19 is here to stay. The world is working out how to live with it
People will have to change their behaviour to prevent second waves of the virus
Paid sick leave to protect income, health and jobs through the COVID-19 crisis
This brief discusses policy developments and evidence on the incidence of sick leave during the first three months of the crisis.It concludes that paid sick leave can be a particularly effective tool during de-confinement, as part of a rigorous testing, tracking,tracing and isolating strategy.
COVID-19 & Global Capital Flows
The COVID-19 outbreak, in addition to dramatic implications for the health of people around the world, has triggered major economic and financial consequences: GDP is now expected to contract by 6% globally in 2020; trade could fall by 12% to 32% this year; FDI flows are expected to fall by around 40%; equity markets initially suffered sharp sell-offs before recovering somewhat in recent weeks, and financial conditions have substantially tightened.
COVID-19 highlights need for companies to protect domestic abuse victims
Some countries have passed laws obliging companies to help abuse victims by offering flexible working and extra leave
COVID-19 and gender monitor
Gender must be integrated in COVID-19 response plans, not only to achieve better outcomes for women and girls but to build stronger and more resilient economies and societies for everyone. Hosted on the UN Women Data Hub, this dashboard is a compilation of indicators that will inform gender-responsive policy action on COVID-19. It is an interagency collaboration that has benefitted from the inputs of ILO, ITU, UNCTAD, UNDP, UN-Habitat, UNHCR, UNICEF, UNODC, UN Women, WFP, WHO, and many others.
What's really behind the gender gap in COVID-19 deaths?
More men than women are dying of COVID-19. The numbers are striking. In Italy, men in their 50s died at four times the rate of women in their 50s. Globally, twice as many men than women may be dying of COVID-19.
The pandemic exposes gendered data gaps that could limit an equal recovery
Since the first cases began to emerge in Wuhan at the start of 2020, it's been clear that COVID-19 disproportionately affects men. While women and men are equally likely to contract the disease, men are dying at higher rates than women in the majority of countries that report data that is disaggregated or broken down, by sex.
1st WHO Infodemiology Conference
When: 21 July 2020 15:00 CET
Topic: Outcomes of the 1st WHO Infodemiology Conference
Updated WHO Myth buster
WGH has partnered with Corona Diaries to collect the stories of frontline health workers fighting coronavirus! Please share with your networks and record your stories: https://coronadiaries.io/index.html
What's wrong with WhatsApp
As social media has become more inhospitable, the appeal of private online groups has grown. But they hold their own dangers – to those both inside and out.
WhatsApp, along with Facebook and YouTube, was a key channel through which the conspiracy theory proliferated.
Combating Misinformation and Rumours
WHO Technical guidance
The CDC published new guidance on COVID-19
Sex, gender and COVID-19: overview and resources
Lancet Coronavirus Resource Centre
This resource brings together new 2019 novel coronavirus (2019-nCoV) content from across The Lancet journals as it is published. All content listed on this page is free to access.
Elsevier’s free health and medical research on novel coronavirus (2019-nCoV)
CIDRAP COVID-19 Resource Center
CIDRAP has created a one-stop comprehensive compilation of the most current, authorititive information available on the novel coronavirus. Visit the Resource Center often, as the outbreak is constantly evolving
COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
100th COVID-19 course launched on OpenWHO
OpenWHO launched its 100th online course to support the response to coronavirus disease on 26 June, exactly 5 months after launching its first COVID-19 course
PAHO sources and materials on COVID19
Research and Development
· Global research on coronavirus disease (COVID-19)
· Database of publications on coronavirus disease (COVID-19)
“Solidarity” clinical trial for COVID-19 treatments
“Solidarity II” global serologic study for COVID-19
Accelerating a safe and effective COVID-19 vaccine
COVID-19 technology access pool
COVID-19 Call to Action: Short – Term Assignments with the WHO Global Outbreak Alert and Response Network (GOARN)
Your expertise is needed to address COVID-19
The GOARN, a collaboration of over 200 institutions and networks that identifies experts willing and able to assist during an outbreak or pandemic, is seeking experts with a minimum of 5-yrs experience in relevant disciplines to help build capacity for the global COVID-19 pandemic response. https://conta.cc/2VPQ0xk
Help Fight Coronavirus- Donate Now
Everyone can now support directly the response coordinated by WHO. People and organizations who want to help fight the pandemic and support WHO and partners can now donate through the COVID-Solidarity Response Fund for WHO at www.COVID19ResponseFund.org.
Thank you for reading. If you have thoughts, feedback, story ideas, or questions you would like to share or interested in partnering with us on a special event coverage, please send a note to Chadia Wannous via firstname.lastname@example.org